Sol-gel announces reverse share split

Ness ziona, israel, may 01, 2025 (globe newswire) -- sol-gel technologies ltd. (the “company”) (nasdaq: slgl), a clinical-stage dermatology company, today announced a reverse share split (the “reverse split”) of the company's issued and outstanding ordinary shares, par value nis 0.1 per share (the “ordinary shares”), at the ratio of 10-for-1, such that each ten (10) ordinary shares shall be consolidated into one (1) ordinary share.
SLGL Ratings Summary
SLGL Quant Ranking